Examples of using Post-natal development in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
Post-natal development.
Effects on post-natal development.
Animal studies performed in rats did not indicate harmful effects on parturition,embryonal/ foetal and post-natal development.
Pre- and post-natal development.
Data from the literature also indicate that decitabine has adverse effects on all aspects of the reproductive cycle, including fertility,embryo-foetal development and post-natal development.
Peri- and Post-Natal Development.
Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonic/foetal development, parturition or post-natal development see section 5.3.
It caused a delay in post-natal development safety margin of 1.
Post-natal development assessment of animals treated prenatally presented decreased glucose tolerance and insulin sensitivity, behavioural alterations and decrease in brain and body weight.
Fertility and pre- and post-natal development were not affected in rats.
Animal studies do not indicate direct or indirect harmful effects with respect to fertility, pregnancy, embryonal/ foetal development, parturition or post-natal development see section 5.3.
No effects were detected in the post-natal development of rat pups.
In a separate pre- and post-natal development study in rats, body weights were lower for male pups following maternal administration at the high dose.
Animal studies to determine the effects of bortezomib parturition and post-natal development were not conducted see section 5.3.
In a study of peri- and post-natal development in rats, retigabine was associated with increased perinatal mortality following administration during pregnancy.
Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryo/foetal development, parturition or post-natal development see section 5.3.
Fertility, pre-natal development and post-natal development were unaffected in rats at doses up to 250 mg/kg/day.
Animal studies do not indicate direct or indirect harmful effects with respect to fertility, pregnancy, embryonal/ foetal development, parturition or post-natal development see section 5.3.
In the pre- and post-natal development study in rats, exposure to rimonabant in utero and via lactation produced no alterations on learning or memory.
Reproductive toxicology Overall, no adverse effects on fertility or post-natal development were observed in the rat at up to 5 times the observed clinical exposure.
In pre- and post-natal development studies with tipranavir in rats, growth inhibition of pups was observed at maternally toxic doses approximating 0.8-fold human exposure.
Amifampridine had no adverse reaction on male or female fertility in rats at doses up to 75 mg/kg/day,and no effect on post-natal development or fertility was observed in the offspring of the treated animals.
In a pre- and post-natal development study in rats, an increase in stillborn pups and reduced embryo/ fetal survival was seen at maternally toxic doses≥ 3 mg/ kg.
Non-clinical data reveal no special hazard for humans based on conventionalstudies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential and toxicity to fertility and post-natal development.
No adverse effects on female reproduction and post-natal development in rats were seen at systemic exposures up to 2,300 times human exposures at the maximum recommended intrathecal dose.
In the pre- and post-natal development study in rats, there were no undesirable effects on pregnancy, parturition or lactation of F0 female rats at maternally non-toxic doses(10 and 20 mg/kg/day) and no effects on the growth, development, neurobehavioral or reproductive function of the offspring F1.
No studies on fertility, early embryonic and post-natal development, or carcinogenicity studies were conducted because chronic dosing in animals would be expected to be associated with development of neutralising antibodies to the human protein.